Piramal Pharma Limited is a diversified global pharmaceutical company offering contract development and manufacturing services (CDMO), complex hospital generics, and consumer healthcare products. Formed as part of the Piramal Group, the company serves pharmaceutical innovators and healthcare providers across more than 100 countries. Piramal Pharma operates an integrated global manufacturing network specializing in active pharmaceutical ingredients, sterile injectables, antibody-drug conjugates, and specialty pharmaceutical products. Its CDMO business supports drug development from early-stage research through commercial manufacturing, making it a strategic partner for leading global biopharmaceutical companies. The company also maintains a growing consumer healthcare portfolio with well-established brands across India. Through investments in advanced manufacturing technologies, quality systems, and scientific expertise, Piramal Pharma continues to strengthen its competitive position in global pharmaceutical outsourcing and specialty therapeutics. The company’s focus on innovation, operational excellence, and customer partnerships supports its long-term growth strategy.
NSE: PPLPHARMA | BSE: 543635
Mumbai, Maharashtra, India
~10,500 employees
